W
William S. Weintraub
Researcher at Christiana Care Health System
Publications - 563
Citations - 39419
William S. Weintraub is an academic researcher from Christiana Care Health System. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 98, co-authored 535 publications receiving 36951 citations. Previous affiliations of William S. Weintraub include St. Vincent's Health System & Emory University.
Papers
More filters
Journal ArticleDOI
Late angiographic status of coronary angioplasaty site which was <50% narrowed 4 to 12 months after successful angioplasty
Journal ArticleDOI
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
William S. Weintraub,Deepak L. Bhatt,Zugui Zhang,Sarahfaye Dolman,William E. Boden,Adam P. Bress,Jordan B. King,Brandon K. Bellows,Gabriel S. Tajeu,Catherine G. Derington,Jonathan C. Johnson,Kate E. Andrade,P. Gabriel Steg,Michael Miller,Eliot A. Brinton,Terry A. Jacobson,Jean-Claude Tardif,Christie M. Ballantyne,Paul Kolm +18 more
TL;DR: This study suggests that, for high-risk patients with hypertriglyceridemia despite statin treatment, icosapent ethyl may be cost-effective at commonly accepted willingness-to-pay thresholds.
Journal ArticleDOI
Predictors of restenosis after excimer laser coronary angioplasty
Ziyad M.B. Ghazzal,Ziyad M.B. Ghazzal,Ziyad M.B. Ghazzal,Erick Burton,Erick Burton,Erick Burton,William S. Weintraub,William S. Weintraub,William S. Weintraub,Frank Litvack,Frank Litvack,Frank Litvack,Donald A. Rothbaum,Donald A. Rothbaum,Donald A. Rothbaum,Larry Klein,Larry Klein,Larry Klein,Spencer B. King,Spencer B. King,Spencer B. King +20 more
TL;DR: Whereas most predictors were not controllable, achieving a low residual diameter stenosis that is operator-dependent can favorably influence the restenosis rate.
Journal ArticleDOI
Technological advances and the next 50 years of cardiology
TL;DR: A future is predicted in which medical science might actually defeat cardiovascular disease the way it has defeated polio, smallpox, and other serious scourges of the past.
Journal ArticleDOI
Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease
TL;DR: Evidence preliminarily supports this practice with coronary artery bypass grafting, and possibly in specific populations undergoing multivessel intervention with functional assessment of lesion severity during PCI.